-
1
Cost-effectiveness of solifenacin compared with oral antimuscarinic agents for the treatment of patients with overactive bladder in the UK
Published 2018-01-01“…Journal of Market Access & Health Policy…”
Get full text
Article -
2
Systematic review of utility values used in the pharmacoeconomic evaluations for schizophrenia: implications on cost-effectiveness results
Published 2019-01-01“…Journal of Market Access & Health Policy…”
Get full text
Article -
3
Analysis of health economics assessment reports for pharmaceuticals in France – understanding the underlying philosophy of CEESP assessment
Published 2017-01-01“…Journal of Market Access & Health Policy…”
Get full text
Article -
4
On the association between SARS-COV-2 variants and COVID-19 mortality during the second wave of the pandemic in Europe
Published 2021-01-01“…Journal of Market Access & Health Policy…”
Get full text
Article -
5
Health economic evaluation of gene replacement therapies: methodological issues and recommendations
Published 2020-01-01“…Journal of Market Access & Health Policy…”
Get full text
Article -
6
Measuring health-related quality of life in young children: how far have we come?
Published 2019-01-01“…Journal of Market Access & Health Policy…”
Get full text
Article